These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14242763)

  • 21. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of saline infusion as replacement fluid at donor plasmapheresis.
    Evers J; Schreiber GB; Taborski U
    J Clin Apher; 2022 Dec; 37(6):611-612. PubMed ID: 36123808
    [No Abstract]   [Full Text] [Related]  

  • 23. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
    Ritter S; Hamouda O; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis.
    Buzza M; Marks DC; Capper H; Cassin E; Badcock CA; Reid S; Kwok M; Yang H; Lee J; Corrigan C; Hartkopf-Theis T; Keller A
    Transfusion; 2012 Aug; 52(8):1806-13. PubMed ID: 22348664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmapheresis for the preparation of HIV free cryoprecipitate.
    Tardtong P; Chuansumrit A; Stabanswadigan S; Chiewsilp P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():195-7. PubMed ID: 7886572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis].
    Nazarchuk LV; Fedorovskaia EA
    Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis].
    Köhler M; Kotitschke R; Braun B; Hellstern P; Mörsdorf S; Pindur G; Heiden M; Wenzel E
    Beitr Infusionsther; 1990; 26():136-41. PubMed ID: 1703813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EFFECTS OF INTENSIVE PLASMAPHERESIS ON NORMAL BLOOD DONORS.
    KLIMAN A; CARBONE PP; GAYDOS LA; FREIREICH EJ
    Blood; 1964 May; 23():647-56. PubMed ID: 14142503
    [No Abstract]   [Full Text] [Related]  

  • 29. A new technique for the collection of plasma: machine plasmapheresis.
    Rock G; McCombie N; Tittley P
    Transfusion; 1981; 21(3):241-6. PubMed ID: 7233508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of red cell mass in a plasmapheresis machine: effect of rinsing the disposable tubing with normal saline and reinfusion.
    Fischer T; Surikova I; Heesen E; Wilms G; Laitinen T; Taborski U
    Transfus Apher Sci; 2013 Aug; 49(1):80-3. PubMed ID: 23769170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
    Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
    Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of plasma donation: A review of the literature.
    Beurel A; Terrade F; Lebaudy JP; Danic B
    Transfus Clin Biol; 2017 Sep; 24(3):106-109. PubMed ID: 28645645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An epidemiological study on hepatitis C among the plasmapheretic donors in two villages with a 5-year history of plasma donation].
    Wang S
    Zhonghua Yi Xue Za Zhi; 1991 Feb; 71(2):76-7, 8. PubMed ID: 1647839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safeguards for plasma donors in plasmapheresis programs.
    JAMA; 1970 Aug; 213(5):743-7. PubMed ID: 5468413
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunoglobulin G levels during collection of large volume plasma for fractionation.
    Burkhardt T; Rothe R; Moog R
    Transfus Apher Sci; 2017 Jun; 56(3):417-420. PubMed ID: 28454884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C virus infection among the plasmapheresis donors].
    Wang S; Ding H; Zhang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):71-3. PubMed ID: 7522967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levels of plasma proteins in blood donors in long-term plasmapheresis. I].
    Smálik S; Beranová G; Strzínek M
    Bratisl Lek Listy; 1971; 56(2):187-96. PubMed ID: 4109999
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood donation (selection of donors, protection of donors and recipients, collection technics, possible complications, methods of blood donation].
    Wegener S
    Z Arztl Fortbild (Jena); 1982 Feb; 76(3):77-82. PubMed ID: 7043917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.